Literature DB >> 6694916

Carcinoma of the prostate: results of post-irradiation biopsy.

F S Freiha, M A Bagshaw.   

Abstract

One hundred and forty-six patients with clinically localized carcinoma of the prostate were surgically staged and treated with external beam irradiation to the prostate and to the lymph node-bearing areas. Sixty-four (44%) of these patients had needle biopsy of the prostate 18 months or more following completion of therapy. Thirty-nine (61%) of the biopsies were interpreted as positive and 25 (39%) as negative. Twenty-eight (72%) of the 39 patients with a positive biopsy have subsequently developed metastases as compared to only 6 of 25 (24%) of the patients with a negative biopsy. It is concluded that an apparently positive postirradiation biopsy is likely to indicate active disease and identifies patients at a higher risk for development of metastases. Other details of staging, grading, and outcomes that compare these two groups are discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6694916     DOI: 10.1002/pros.2990050103

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  2 in total

1.  Radiation therapy failure in prostate cancer patients: risk factors and methods of detection.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2002

2.  Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.

Authors:  Amar U Kishan; Fang-I Chu; Christopher R King; Wendy Seiferheld; Daniel E Spratt; Phuoc Tran; Xiaoyan Wang; Stephanie E Pugh; Kiri A Sandler; Michel Bolla; Philippe Maingon; Theo De Reijke; Nicholas G Nickols; Matthew Rettig; Alexandra Drakaki; Sandy T Liu; Robert E Reiter; Albert J Chang; Felix Y Feng; Dipti Sajed; Paul L Nguyen; Patrick A Kupelian; Michael L Steinberg; Paul C Boutros; David Elashoff; Laurence Collette; Howard M Sandler
Journal:  Eur Urol       Date:  2019-11-10       Impact factor: 20.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.